Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1615 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

WIL Research Laboratories Names New CEO

Mr Spaight is expected to oversee WIL’s four major businesses – WIL Research Laboratories, Notox, Midwest BioResearch and QS Pharma, and will continue to implement a long-term strategy

NeoPharm IPF Drug Receives FDA ODD

Earlier, NeoPharm had filed an investigational new drug application (IND) with the FDA for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF), on Jan 04, 2010.

Roxro Pharma Gets FDA Nod For Sprix Nasal Spray

Sprix is a prescription intranasal formulation of the analgesic ketorolac, a non-steroidal anti-inflammatory drug (NSAID), designed to provide ambulatory patients with a convenient, potent, and fast-acting option for